Apixaban: A Novel Oral Inhibitor of Factor Xa Edith Nutescu, Pharm.D., FCCP Disclosures Am J Health Syst Pharm. 2012;69 (13):1113-1126. 0 ...

Apixaban is currently indicated in Europe for the prevention of VTE in patients who have undergone total knee replacement or total hip replacement. Apixaban is also being investigated in Phase III ...

Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are ...

VC firm Elevation Capital, formerly SAIF Partners India, offloaded over 53.98 Lakh shares of online travel aggregator (OTA) ixigo in a block deal worth INR 97.44 Cr yesterday. As per the BSE data ...

Extended anticoagulation using reduced-dose apixaban was found to be noninferior to using full-dose apixaban in preventing recurrent venous thromboembolism (VTE) in patients who had active cancer ...

Non-banking financing company (NBFC) Techfino has raised INR 65 Cr (around $7.5 Mn) from Stellaris Venture Partners and Saison Capital in an undisclosed funding round. The Bengaluru-based NBFC ...

Infinity Natural Resources Inc. (NYSE:INR) is one of the cheap new stocks to buy according to analysts. On June 11, Raymond James raised its price target on Infinity Natural Resources to $28 from ...

Between now and 2028, Pfizer will lose patent exclusivity for Inlyta, Xeljanz, Prevnar 13, Eliquis, Ibrance, Mektovi, Xtandi, and Vyndaqel. Five of those eight products were blockbusters last year.

Indian Rupee to Solomon Islands Dollar conversion - Last updated Jun 16, 2025 14:46 UTC Result 0.097149 Solomon Islands Dollar 1 INR = 0.097149 SBD 1 SBD = 10.293466737 INR ...

With the growing computational power available for high-resolution ensemble simulations in scientific fields such as cosmology and oceanology, storage and computational demands present significant ...

View the latest Infinity Natural Resources Inc. (INR) stock price, news, historical charts, analyst ratings and financial information from WSJ.